{"lastClose": 27.809999465942383, "len": 312, "date": "2023-04-05", "alpha_1": 3.020223204919062, "beta_1": 1.063925250057174, "drawup_1": 4.9751826094910365, "sharpe_1": 1.1549850944003892, "natr_1": 7.79635822854135, "sup_1": -0.03475972059113763, "res_1": 0.08725878972131351, "bullPattern_1": ["MATCHINGLOW"], "bearPattern_1": [], "rsi_1": 38.25849176937717, "adx_1": 25.312903182424044, "drawdown_1": -0.5179451170834881, "stratHoldSharpe_1": 1.181550699090541, "stratHoldAlpha_1": 252.07675323184566, "stratHoldDrawdown_1": -0.46938776399763893, "alpha_3mo": -0.7236200594396854, "beta_3mo": 1.3675421723377024, "drawup_3mo": 0.18534612661834649, "natr_3mo": 7.79635822854135, "sup_3mo": -0.08114580924999855, "res_3mo": 0.14838790858452533, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 34.86888163288479, "adx_3mo": 38.29313686511728, "drawdown_3mo": -0.3229904989527058, "stratHoldSharpe_3mo": -1.6098239897855204, "stratHoldAlpha_3mo": 250.14204860103808, "stratHoldDrawdown_3mo": -0.2940900461087397, "IPO Year": 2022.0, "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United States", "Market Cap": 1855382750, "Name": "Amylyx Pharmaceuticals Inc.", "Sector": "Health Care", "alpha%_1": 1.0, "beta%_1": 0.5674191541987901, "drawup%_1": 1.0, "sharpe%_1": 0.8801459337167096, "natr%_1": 0.930131997922483, "drawdown%_1": 0.2305848545517099, "stratHoldSharpe%_1": 0.9474756795584693, "stratHoldAlpha%_1": 0.9999705305726605, "stratHoldDrawdown%_1": 0.23206322678750085, "alpha%_3mo": 0.15557361422122895, "beta%_3mo": 0.6977132455976324, "drawup%_3mo": 0.5234077643676578, "natr%_3mo": 0.9242482966775275, "drawdown%_3mo": 0.14309347676922413, "stratHoldSharpe%_3mo": 0.17943239545376843, "stratHoldAlpha%_3mo": 0.08134503747523258, "stratHoldDrawdown%_3mo": 0.14326215406151938}